SlideShare ist ein Scribd-Unternehmen logo
1 von 40
Downloaden Sie, um offline zu lesen
Biochemical tests in clinical
medicine
Dr. Hala Kamel
MBChB, MSc, MD
Assist. prof. Biochemistry Dep.,
Faculty of Medicine
ASU & UQ
Clinical Biochemistry
History
Clinical Examination
Diagnostic services
Laboratory services
Clinical Biochemistry
Clinical Biochemistry Laboratory
Clinical biochemistry Laboratory play an
important, often unrecognised role, in disease
diagnosis and the monitoring of treatment.
•They are responsible for most laboratory testing
performed on samples sent to the diagnostic
laboratory by medical practitioners.
•Laboratory results produced by MLS‟s are used
by medical staff in the diagnosis of disorders in
approx. 70% of all patient cases.
Clinical Biochemistry
• Analysis of the chemical constituents of
the blood, urine, faeces and tissues.
• Most of the laboratory testing uses
sophisticated instrumentation interfaced to
a laboratory information system.
• Diseases such as diabetes, renal failure,
heart attack, drug analysis and hepatitis
are some of the conditions investigated by
clinical biochemists.
Introduction
• Clinical Biochemistry
• Dissolved elements in body fluids
• Concentration and type e.g. glucose,
electrolytes, hormones and significance of
levels and interpretation.
• Accurate and precise laboratory
measurements can aid in diagnosis and
management of disease
Uses of Biochemical tests
• 1- Diagnosis
• 2- Screening
• 3-Prognosis
• 4- Treatment
Use of Biochemical Tests
• 1-Diagnosis
• History and Physical Examination of patient --form
Differential Diagnosis i.e. Hypothesis
• Lab tests and Radiology to support or reject hypothesis.
Limitations of tests must be appreciated
• Interpretation must be carefully done in context of clinical
details
2-Screening
• Detection of sub-clinical
• Neonatal screening PKU, CHT
• Criteria for same.
• Natural history known
• Acceptable tests no false negatives, few
false positives
• Ease of treatment
• Positive outcome
Screening
• Natural history of disease
• Acceptable and reliable screening Tests,
FP issues
• Therapy available
• Prevalence
• Entire population
• or “at risk groups”
3-Prognosis
• Serial tests to identify progressive
disease creatinine in renal failure
• Tests to identify risks of disease in future
in certain groups cholesterol in “at risk
families”
• Calculation of risk depends on
epidemiological data
• Likely outcome of disease
Sampling
• Test Request
• Clinician requests that analysis be conducted.
• Requirements
• Name, DOB, Gender, Hos. No. MRN
• Ward, Address
• Requesting Clinician
• Hypothesis / Problem
• Tests sought,time of sampling,date
• Clinical details, Drugs or Therapy.
Sampling Issues.
• Patient Centred Factors
• Age
• Gender
• Posture
• Physiological State
• Pregnancy
• Exercise
• Fasting / Fed
• Time
Sampling contd.
• Plasma,serum
• Bottle and preservative, anti coagulant used
• Age of sample
• Time of sampling
• Guidance from lab on sample requirements
• Correct label
• Transport
• High risk specimen.
Variation
Patient Variables :
• Age, gender, fasting, time of day, exercise,
posture, need to document these.
• Biological Variation
• Pre-Analytical Variation
• Sample site, type of bottle
• Transportation to lab.
• Stability of analyte age
• Analytical Variation
• Post Analytical Interpretation
Analysis
• Accuracy & Precision
• Detection limits
• Specificity& sensitivity
• quality assurance
• reference ranges
Precision and accuracy
• Precision is the reproducibility of an
analytical method.
• If there is 2 methods performed for the
same analyte repeated measurement of
the same analyte will show more closed
results to each others ( less scattering )
• Repeated measurement of an analyte will
be close to each other if precise
Precision and accuracy
• Accuracy defines how close the measured
value is to the actual value.
• Accuracy is therefore poor, as if the „sights‟ are off. so
repeated measurement of an analyte is accurate if it is
very close to actual value known before
• It is the objective in every biochemical method to
provide good precision and accuracy.
• Automation of analyses has improved precision
in most cases.
Precision and Accuracy
Diagnostic Sensitivity
Positive test result in presence of disease.
Diagnostic Specificity
Negative test result with no disease.
Diagnostic Sensitivity = TP
TP + FN
Diagnostic Specificity = TN
FP+ TN
Analytical sensitivity and
specificity
• The analytical sensitivity of an assay is a
measure of how little of the analyte the method
can detect to improve the detection limit to help
in discrimination normal results and those with
suspected disease( Positivity in disease)
• Analytical specificity of an assay relates to how
good the assay is at discriminating between the
requested analyte and potentially interfering
substances. So it measures the negativity in
normal results
ROC CURVES A,B,C
Test Efficiency and Predictive
Values
TE = TP +TN X 100
Total No. of Tests
PV Pos = TP X 100
TP + FP
PV Neg = TN X 100
TN + FN
Features of PD pos. and PD neg.
• Prevalence of disease in population.
• Low prevalence with less than 100%
specificity high FP will result in low PV
• Screening with follow up testing should have
a high PV neg.
Likelihood Ratios
• LR pos = Sens. /1 – Spec.
• LR neg = Spec. / 1- Sens.
Reference Ranges
• Mean ± 2SD Mean
-1SD +1SD
-2SD +2SD
Healthy and Diseased Reference range
healthy
diseased
Biological Factors affecting
interpretation
• Sex
• Age
• Diet
• Time of sampling
• Stress and anxiety
• Posture
• Exercise
• Medical History
• Pregnancy
• Menstrual cycle
• Drug History
Is It Different?
SD2 =  SD2
anal + SD2biol.
Receiving the report
• Does the results fit in with the excepted?
• If not, how to explain the discrepancy?
• How can the results change the
diagnosis?
• How to manage that patient?
• What should be done?
Interpretation
• Is Result Normal?
• Has it changed?
• Does it support the clinical hypothesis?
Does it Support the Hypothesis?
• Consistent support diagnosis
• Inconsistent needs explanation
• Error in sampling, patient labelling
analysis,or reporting.
• Repeat test
• ? Diagnosis
• Statistical random event abnormal test no
disease.
• Diagnostic Utility : Sensitivity, Specificity
Errors
• Pre-analytical
• Analytical
• Post-analytical,
• Interpretation,
• Delays
• Wrong records
Biochemical tests performed outside laboratory
(Blood)
Point of care testing
Analyte Test when investing Operator
Blood Gasses
Glucose
Urea/Creatinine
Bilirubin
Salicylates /Paracetamol
Therapeutic drugs
Acid – Base status
DM
Renal disease
Neonatal Jaundice
Detection of poisoning
Compliance or toxicity
Medical or Nursing
setting
Glucose
cholesterol
Diabetic monitoring
Coronary heart disease
risk
Home or clinical
setting
Alcohol Fitness to drive/
confusion ,coma
Alcohol test
Biochemical tests performed
outside laboratory (Urine)
Analyte Test when investing Operator
Ketones
Protein
Red cells/Hemoglobin
Bilirubin
Urobilinogen
PH
Diabetic ketoacidosis
Renal disease
Renal disease
Liver disease/ Jaundice
Jaundice/ Haemolysis
Renal tubular acidosis
Medical or Nursing
setting
Glucose
hCG
D.M.
Pregnancy test
Home or clinical
setting
POCT: Advantages
• Faster stabilization of life-threatening crises (eg
drug overdose, electrolyte disturbance)
• Immediate risk stratification (eg chest pain)
• Closer therapeutic management (eg diabetes)
• Better patient compliance with therapy (diabetes,
anticoagulation, hyperlipidaemia)
• Reduce:
– repeat clinic/practice visits
– length of stay in hospital
– complications (intra- & postoperative)
– use of blood products (surgery)

Weitere ähnliche Inhalte

Was ist angesagt?

Laboratory errors in medical practice
Laboratory  errors in medical practiceLaboratory  errors in medical practice
Laboratory errors in medical practice
MedicineBSMMU
 

Was ist angesagt? (20)

Hb electrophoresis (principle materials and procedure)
Hb electrophoresis (principle materials and procedure)Hb electrophoresis (principle materials and procedure)
Hb electrophoresis (principle materials and procedure)
 
Automation in the Clinical Lab
Automation in the Clinical LabAutomation in the Clinical Lab
Automation in the Clinical Lab
 
Establishment Of reference Interval
Establishment Of reference IntervalEstablishment Of reference Interval
Establishment Of reference Interval
 
Laboratory errors in medical practice
Laboratory  errors in medical practiceLaboratory  errors in medical practice
Laboratory errors in medical practice
 
Automation in hematology
Automation in hematologyAutomation in hematology
Automation in hematology
 
Blood component separation
Blood component separationBlood component separation
Blood component separation
 
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care DeliveryPoint of Care Testing for Enhancing Patient Centered Planned Care Delivery
Point of Care Testing for Enhancing Patient Centered Planned Care Delivery
 
Quality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistryQuality assurance in the department of clinical biochemistry
Quality assurance in the department of clinical biochemistry
 
Preanalytical quality control practices in clinical laboratory
Preanalytical quality control practices in clinical laboratoryPreanalytical quality control practices in clinical laboratory
Preanalytical quality control practices in clinical laboratory
 
Automation
AutomationAutomation
Automation
 
Quality control in clinical biochemistry
Quality control in clinical biochemistryQuality control in clinical biochemistry
Quality control in clinical biochemistry
 
Quality Assurance in Hematology laboratory
Quality Assurance in Hematology laboratoryQuality Assurance in Hematology laboratory
Quality Assurance in Hematology laboratory
 
PRINCIPLES OF OPERATIONOF THE AUTOMATED COAGULATION ANALZER.pptx
PRINCIPLES OF OPERATIONOF THE AUTOMATED COAGULATION ANALZER.pptxPRINCIPLES OF OPERATIONOF THE AUTOMATED COAGULATION ANALZER.pptx
PRINCIPLES OF OPERATIONOF THE AUTOMATED COAGULATION ANALZER.pptx
 
Lipid profile test
Lipid profile testLipid profile test
Lipid profile test
 
Automation in Clinical Biochemistry.pptx
Automation in Clinical Biochemistry.pptxAutomation in Clinical Biochemistry.pptx
Automation in Clinical Biochemistry.pptx
 
Quality Control
Quality ControlQuality Control
Quality Control
 
Clinical Hematology Laboratory
Clinical Hematology LaboratoryClinical Hematology Laboratory
Clinical Hematology Laboratory
 
Analytical and post analytical errors in laboratory
Analytical and post analytical errors in laboratoryAnalytical and post analytical errors in laboratory
Analytical and post analytical errors in laboratory
 
Auto analyzer
Auto analyzerAuto analyzer
Auto analyzer
 
Point of care testing ( POCT)
Point of care testing ( POCT)Point of care testing ( POCT)
Point of care testing ( POCT)
 

Ähnlich wie Biochemical tests in clinical medicine lect1

Monitoring response variables 13Feb2014
Monitoring response variables 13Feb2014Monitoring response variables 13Feb2014
Monitoring response variables 13Feb2014
Thira Woratanarat
 

Ähnlich wie Biochemical tests in clinical medicine lect1 (20)

Techniques in clinical epidemiology
Techniques in clinical epidemiologyTechniques in clinical epidemiology
Techniques in clinical epidemiology
 
H.Assessment Bates Chapter#02.pptx
H.Assessment Bates Chapter#02.pptxH.Assessment Bates Chapter#02.pptx
H.Assessment Bates Chapter#02.pptx
 
H.Assessment Bates Chapter#02.pptx
H.Assessment Bates Chapter#02.pptxH.Assessment Bates Chapter#02.pptx
H.Assessment Bates Chapter#02.pptx
 
Screening of disease
Screening of diseaseScreening of disease
Screening of disease
 
Preoperative Evaluation- Anaesthesia
Preoperative Evaluation- AnaesthesiaPreoperative Evaluation- Anaesthesia
Preoperative Evaluation- Anaesthesia
 
Clinical Pharmacy
Clinical PharmacyClinical Pharmacy
Clinical Pharmacy
 
Screening
ScreeningScreening
Screening
 
Screening
ScreeningScreening
Screening
 
Types of studies 2016
Types of studies 2016Types of studies 2016
Types of studies 2016
 
Pathology Optimisation in Chronic Blood Disease Monitoring
Pathology Optimisation in Chronic Blood Disease MonitoringPathology Optimisation in Chronic Blood Disease Monitoring
Pathology Optimisation in Chronic Blood Disease Monitoring
 
The comprehensive geriatric assessment pcp slides
The comprehensive geriatric assessment  pcp slidesThe comprehensive geriatric assessment  pcp slides
The comprehensive geriatric assessment pcp slides
 
EBM.ppt
EBM.pptEBM.ppt
EBM.ppt
 
Epidemiology Lectures for UG
Epidemiology Lectures for UGEpidemiology Lectures for UG
Epidemiology Lectures for UG
 
biomarkers by Dr Rajesh.pptx
biomarkers by Dr Rajesh.pptxbiomarkers by Dr Rajesh.pptx
biomarkers by Dr Rajesh.pptx
 
MedMAP finger prick blood test presentation from MaxiMedrx.com
MedMAP finger prick blood test presentation from MaxiMedrx.comMedMAP finger prick blood test presentation from MaxiMedrx.com
MedMAP finger prick blood test presentation from MaxiMedrx.com
 
Monitoring response variables 13Feb2014
Monitoring response variables 13Feb2014Monitoring response variables 13Feb2014
Monitoring response variables 13Feb2014
 
Overview of the, clinicianb
Overview of the, clinicianbOverview of the, clinicianb
Overview of the, clinicianb
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
Diagnostic test and agreement.pptx
Diagnostic test and agreement.pptxDiagnostic test and agreement.pptx
Diagnostic test and agreement.pptx
 
Introduction to internal medicine
Introduction to internal medicineIntroduction to internal medicine
Introduction to internal medicine
 

Kürzlich hochgeladen

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

Kürzlich hochgeladen (20)

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural ResourcesEnergy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
Energy Resources. ( B. Pharmacy, 1st Year, Sem-II) Natural Resources
 

Biochemical tests in clinical medicine lect1

  • 1. Biochemical tests in clinical medicine Dr. Hala Kamel MBChB, MSc, MD Assist. prof. Biochemistry Dep., Faculty of Medicine ASU & UQ
  • 2. Clinical Biochemistry History Clinical Examination Diagnostic services Laboratory services Clinical Biochemistry
  • 3. Clinical Biochemistry Laboratory Clinical biochemistry Laboratory play an important, often unrecognised role, in disease diagnosis and the monitoring of treatment. •They are responsible for most laboratory testing performed on samples sent to the diagnostic laboratory by medical practitioners. •Laboratory results produced by MLS‟s are used by medical staff in the diagnosis of disorders in approx. 70% of all patient cases.
  • 4. Clinical Biochemistry • Analysis of the chemical constituents of the blood, urine, faeces and tissues. • Most of the laboratory testing uses sophisticated instrumentation interfaced to a laboratory information system. • Diseases such as diabetes, renal failure, heart attack, drug analysis and hepatitis are some of the conditions investigated by clinical biochemists.
  • 5. Introduction • Clinical Biochemistry • Dissolved elements in body fluids • Concentration and type e.g. glucose, electrolytes, hormones and significance of levels and interpretation. • Accurate and precise laboratory measurements can aid in diagnosis and management of disease
  • 6.
  • 7. Uses of Biochemical tests • 1- Diagnosis • 2- Screening • 3-Prognosis • 4- Treatment
  • 8. Use of Biochemical Tests • 1-Diagnosis • History and Physical Examination of patient --form Differential Diagnosis i.e. Hypothesis • Lab tests and Radiology to support or reject hypothesis. Limitations of tests must be appreciated • Interpretation must be carefully done in context of clinical details
  • 9. 2-Screening • Detection of sub-clinical • Neonatal screening PKU, CHT • Criteria for same. • Natural history known • Acceptable tests no false negatives, few false positives • Ease of treatment • Positive outcome
  • 10. Screening • Natural history of disease • Acceptable and reliable screening Tests, FP issues • Therapy available • Prevalence • Entire population • or “at risk groups”
  • 11. 3-Prognosis • Serial tests to identify progressive disease creatinine in renal failure • Tests to identify risks of disease in future in certain groups cholesterol in “at risk families” • Calculation of risk depends on epidemiological data • Likely outcome of disease
  • 12. Sampling • Test Request • Clinician requests that analysis be conducted. • Requirements • Name, DOB, Gender, Hos. No. MRN • Ward, Address • Requesting Clinician • Hypothesis / Problem • Tests sought,time of sampling,date • Clinical details, Drugs or Therapy.
  • 13. Sampling Issues. • Patient Centred Factors • Age • Gender • Posture • Physiological State • Pregnancy • Exercise • Fasting / Fed • Time
  • 14. Sampling contd. • Plasma,serum • Bottle and preservative, anti coagulant used • Age of sample • Time of sampling • Guidance from lab on sample requirements • Correct label • Transport • High risk specimen.
  • 15. Variation Patient Variables : • Age, gender, fasting, time of day, exercise, posture, need to document these. • Biological Variation • Pre-Analytical Variation • Sample site, type of bottle • Transportation to lab. • Stability of analyte age • Analytical Variation • Post Analytical Interpretation
  • 16. Analysis • Accuracy & Precision • Detection limits • Specificity& sensitivity • quality assurance • reference ranges
  • 17. Precision and accuracy • Precision is the reproducibility of an analytical method. • If there is 2 methods performed for the same analyte repeated measurement of the same analyte will show more closed results to each others ( less scattering ) • Repeated measurement of an analyte will be close to each other if precise
  • 18. Precision and accuracy • Accuracy defines how close the measured value is to the actual value. • Accuracy is therefore poor, as if the „sights‟ are off. so repeated measurement of an analyte is accurate if it is very close to actual value known before • It is the objective in every biochemical method to provide good precision and accuracy. • Automation of analyses has improved precision in most cases.
  • 20. Diagnostic Sensitivity Positive test result in presence of disease. Diagnostic Specificity Negative test result with no disease. Diagnostic Sensitivity = TP TP + FN Diagnostic Specificity = TN FP+ TN
  • 21. Analytical sensitivity and specificity • The analytical sensitivity of an assay is a measure of how little of the analyte the method can detect to improve the detection limit to help in discrimination normal results and those with suspected disease( Positivity in disease) • Analytical specificity of an assay relates to how good the assay is at discriminating between the requested analyte and potentially interfering substances. So it measures the negativity in normal results
  • 23. Test Efficiency and Predictive Values TE = TP +TN X 100 Total No. of Tests PV Pos = TP X 100 TP + FP PV Neg = TN X 100 TN + FN
  • 24. Features of PD pos. and PD neg. • Prevalence of disease in population. • Low prevalence with less than 100% specificity high FP will result in low PV • Screening with follow up testing should have a high PV neg.
  • 25. Likelihood Ratios • LR pos = Sens. /1 – Spec. • LR neg = Spec. / 1- Sens.
  • 26.
  • 27. Reference Ranges • Mean ± 2SD Mean -1SD +1SD -2SD +2SD
  • 28. Healthy and Diseased Reference range healthy diseased
  • 29.
  • 30.
  • 31.
  • 32. Biological Factors affecting interpretation • Sex • Age • Diet • Time of sampling • Stress and anxiety • Posture • Exercise • Medical History • Pregnancy • Menstrual cycle • Drug History
  • 33. Is It Different? SD2 =  SD2 anal + SD2biol.
  • 34. Receiving the report • Does the results fit in with the excepted? • If not, how to explain the discrepancy? • How can the results change the diagnosis? • How to manage that patient? • What should be done?
  • 35. Interpretation • Is Result Normal? • Has it changed? • Does it support the clinical hypothesis?
  • 36. Does it Support the Hypothesis? • Consistent support diagnosis • Inconsistent needs explanation • Error in sampling, patient labelling analysis,or reporting. • Repeat test • ? Diagnosis • Statistical random event abnormal test no disease. • Diagnostic Utility : Sensitivity, Specificity
  • 37. Errors • Pre-analytical • Analytical • Post-analytical, • Interpretation, • Delays • Wrong records
  • 38. Biochemical tests performed outside laboratory (Blood) Point of care testing Analyte Test when investing Operator Blood Gasses Glucose Urea/Creatinine Bilirubin Salicylates /Paracetamol Therapeutic drugs Acid – Base status DM Renal disease Neonatal Jaundice Detection of poisoning Compliance or toxicity Medical or Nursing setting Glucose cholesterol Diabetic monitoring Coronary heart disease risk Home or clinical setting Alcohol Fitness to drive/ confusion ,coma Alcohol test
  • 39. Biochemical tests performed outside laboratory (Urine) Analyte Test when investing Operator Ketones Protein Red cells/Hemoglobin Bilirubin Urobilinogen PH Diabetic ketoacidosis Renal disease Renal disease Liver disease/ Jaundice Jaundice/ Haemolysis Renal tubular acidosis Medical or Nursing setting Glucose hCG D.M. Pregnancy test Home or clinical setting
  • 40. POCT: Advantages • Faster stabilization of life-threatening crises (eg drug overdose, electrolyte disturbance) • Immediate risk stratification (eg chest pain) • Closer therapeutic management (eg diabetes) • Better patient compliance with therapy (diabetes, anticoagulation, hyperlipidaemia) • Reduce: – repeat clinic/practice visits – length of stay in hospital – complications (intra- & postoperative) – use of blood products (surgery)